Researchers Identify New Cost Savings and Accuracy of C2N Diagnostics' Blood Tests to Enable Healthcare Providers to Better Identify Alzheimer's Disease | Business

ST. LOUIS--(BUSINESS WIRE)--Nov 16, 2023--

Related Keywords

United States ,Robert Rissman ,Adam Shapiro ,Chengjie Xiong ,Joni Henderson ,Joel Braunstein ,Mark Monane ,Suzanne Schindler ,Research Use Only ,Eisai Co Ltd ,2n Diagnostics ,Brightfocus Foundation ,Alzheimer Association ,Alzheimer Drug Discovery Foundation ,National Institute On ,Washington University School Of Medicine ,Clinical Trials ,Blood Test Showed Economic Utility ,Senior Medical Advisor ,Blood Test Demonstrated Analytic ,Vice President ,Amyloid Probability Score ,Biomarker Test Data Shared ,Endowed Professor ,Keck School ,Southern California ,Associate Professor ,Washington University School ,Clarity Through Innovation ,National Institute ,Drug Discovery Foundation ,Business Wire ,Business ,